EGFR and cancer: EGFR is a receptor tyrosine kinase42, including EGFR (ErbB-1, HER1), HER2 (ErbB2/neu), etc. Studies have shown that ErbB2-4 has potential roles in regulating cardiomyocyte proliferation and cardiotoxicity related to cancer treatment.